Low Evidence
Research Overview
Follistatin Research for Sporadic Inclusion Body Myositis
An evidence-based overview of research examining Follistatin in the context of sporadic inclusion body myositis. This page synthesizes findings from peer-reviewed literature.
Research Summary
Six treated participants received AAV1-FS344 gene transfer alongside an exercise regimen and were compared with eight matched untreated people. The reported walking difference is vulnerable to the small, nonrandomized design and has been challenged in published correspondence. It does not establish efficacy for injected follistatin protein.
Referenced Studies
Click any PMID to view the full study on PubMed.
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Always consult a healthcare provider before making health decisions.